I’ve Prescribed Neurolens 400+ Times for BVD. Here’s What I Think.

I have been fitting patients suffering from Binocular Vision Dysfunction (BVD) with Neurolens glasses for approximately three years and have now dispensed more than 400 pairs.

That's enough time for the novelty to wear off. I've seen remarkable successes, some failures, and enough patients in between to develop a pretty strong opinion about where this technology belongs.

So, three years in, what do I actually think?

Neurolens is one of the most clinically meaningful technologies I have added in nearly 20 years of practice.

In the right patient with Binocular Vision Dysfunction, I think it's genuinely amazing.

The important part of that sentence is “the right patient.”

When “Your Eyes Are Fine” Doesn't Answer the Question

Many of my Neurolens patients have almost no glasses prescription. Their eyes are healthy. They see 20/20. Often they've already had several eye exams and have repeatedly been told:

“Your eyes are fine.”

Technically, that's true.

But they're experiencing headaches during computer work, sore eyes, neck tension, difficulty focusing, motion sickness, or disorientation in large, visually busy environments. Navigating Costco, in particular, seems to function as an unofficial binocular vision stress test with bulk muffins.

The important distinction is simple:

Clear vision and comfortable vision are not the same thing.

Your eyes don't just have to see clearly. They have to aim, focus, track and remain coordinated all day. When that binocular vision system is struggling, the symptom isn't necessarily blur or double vision. It can be headache, fatigue, neck tension, dizziness or simply feeling lousy.

This is the basic problem in Binocular Vision Dysfunction: the eyes may be healthy and vision may be clear, but keeping the two eyes comfortably coordinated can place excessive demand on the visual system.

And the idea that our eyes can make us feel lousy really isn't much of a stretch.

Put on somebody else's glasses with the wrong prescription and walk around. Repeatedly cross your eyes. Watch a 3D movie your visual system doesn't particularly enjoy. Most people can produce eyestrain, nausea, dizziness or a headache surprisingly quickly.

So the interesting question isn't whether visual stress can make someone uncomfortable. Clearly it can.

The clinical challenge is figuring out whose visual system is contributing enough strain, hour after hour, to actually be driving or amplifying their symptoms.

After several years of specifically looking for Binocular Vision Dysfunction and these visually driven symptom patterns, I think I've become pretty good at finding them.

Why I Use Neurolens for BVD

Prism isn't new. Optometrists have prescribed it for decades for binocular vision problems.

Neurolens uses contoured prism. Instead of providing the same prism throughout the lens, the amount changes, typically providing more at near, where binocular demands are different.

When I first encountered Neurolens, I wondered whether this was simply regular prism wearing a nicer suit and charging more for parking.

After 400+ prescriptions, I don't think it is.

I've prescribed conventional prism for years. In patients with Binocular Vision Dysfunction and visually triggered headaches, eyestrain, neck discomfort, motion sensitivity and visual disorientation, the responses I see with Neurolens can be very different.

Sometimes dramatically so.

Patients occasionally put the glasses on and immediately say that things simply feel easier. Their face relaxes. Their shoulders drop. Some become emotional.

Testimonials aren't science. But repeated clinical experience isn't meaningless either. When you see variations of the same response across hundreds of patients, you pay attention.

And I have.

What Does the Science Say?

The science is encouraging, although I don't think it has completely caught up with what we're learning clinically.

A randomized, double-masked crossover trial of 195 patients with significant headaches found that Neurolens statistically outperformed control lenses. The average difference on the HIT-6 headache questionnaire, however, was only 1.53 points.

That's a real but modest average effect.

I think there is an important question hiding inside that result.

The study looked at people with significant headaches. But “people with headaches” and “people whose headaches are being driven or amplified by Binocular Vision Dysfunction” are not necessarily the same population.

Headaches have dozens of causes. Migraine, neck problems, sleep, stress, medications and many other things can produce a high headache score. I wouldn't expect prism to substantially improve a headache that has little to do with vision.

Imagine testing an asthma inhaler in everyone with a bad cough.

Some have asthma. Others have reflux, allergies or an infection. Average everyone together and the inhaler may look fairly unimpressive.

That doesn't mean inhalers don't work. It means identifying the right patient matters.

I suspect Neurolens is similar.

The patients who catch my attention aren't simply people who check the “headaches” box. I'm looking for headaches provoked by reading or computer work, symptoms that build with sustained near tasks, significant eyestrain or neck tension, motion sensitivity, discomfort in visually busy environments, difficulty sustaining focus despite clear vision, and other clues of Binocular Vision Dysfunction or that the visual system is involved.

A modest average treatment effect could theoretically contain some patients who respond extraordinarily well and others whose headaches never had much visual component to begin with.

That hypothesis still needs better prospective research. I'd particularly like to see studies specifically selecting patients with strongly visually driven symptom patterns and comparing contoured prism with conventional prism and control lenses.

But clinically, after more than 400 prescriptions, I am comfortable saying something much stronger than I would have three years ago:

For appropriately selected patients with BVD, Neurolens can be remarkably effective.

The Part of My Approach That Matters Most

There is one thing I still can't do.

I can't guarantee that I'm right.

I can take a detailed history, measure binocular vision, reproduce symptoms, look for visual triggers and identify someone who, based on everything I've learned over the past several years, looks like an excellent Neurolens candidate.

Most of the time, I'm increasingly confident in that judgment.

But ultimately there is only one test that matters: does the patient actually feel substantially better wearing the glasses?

That uncertainty has shaped how I offer Neurolens in my practice.

I don't think a patient should have to make an expensive bet on whether my prediction is correct.

So if I recommend Neurolens, I offer the patient a 100% money-back guarantee. If we try the lenses and they don't provide enough benefit to justify keeping them, they can return them and get their money back.

That changes the conversation considerably.

I'm not asking someone with chronic headaches or other BVD symptoms to spend a significant amount of money and simply trust me that this will work.

I'm saying: I think your history and testing suggest that your visual system is contributing to your symptoms. I think Neurolens has a legitimate chance of making you feel substantially better. Let's try it. If I'm wrong, I don't want you stuck paying for my wrong prediction.

I think that's a particularly useful approach in headache treatment, because very few treatments allow us to do this.

Consider Botox for migraine. It can be tremendously helpful for the right patient, but you can't exactly try it for a few weeks, decide it didn't work, have someone suck the Botox back out and refund your money.

Medications, injections, physiotherapy, massage and most other treatments work similarly. You pay for the treatment whether you ultimately respond or not.

Neurolens are different.

I can actually remove much of that financial risk from the experiment.

And that lets me do something I think is clinically valuable: offer Neurolens not only to the slam-dunk BVD cases, but also to patients where I think there is a meaningful possibility that visual stress is contributing to their symptoms.

Sometimes those patients surprise me.

The Number I Keep Coming Back To

There's another reason I've become increasingly confident in this approach.

Currently, fewer than 5% of the Neurolens prescriptions in my practice are returned.

I want to be careful with that number. It isn't a clinical trial. It doesn't objectively measure symptom improvement, and I wouldn't pretend that a 95% retention rate proves Neurolens works.

But I do think it's meaningful, particularly when you consider what these lenses cost.

Depending on the prescription and lens design, Neurolens typically cost roughly $900–$1,200 plus the price of the chosen frame. That's real money. If someone spends $1,000 on a treatment, notices only a trivial improvement, and knows they can return it for a full refund, there is a pretty strong financial incentive to do exactly that.

Yet fewer than 5% of my Neurolens patients do.

These patients have an easy way out. If the improvement isn't enough to justify the cost, they can bring the glasses back and get their money back.

More than 95% choose to keep them.

Again, that doesn't tell me whether someone's headaches improved by 20%, 50% or 90%. But it does tell me something that matters in the real world: the overwhelming majority of my patients apparently feel the benefit is valuable enough that they would rather keep a $900–$1,200 treatment than take the money back.

And that's a fairly high bar.

If these lenses were consistently producing only tiny, barely perceptible improvements, I would expect a lot more people to take the $1,000 back.

After more than 400 prescriptions, the fact that so few do has become one of the strongest pieces of practical feedback I have about both the technology and our ability to identify the BVD patients most likely to benefit from it.

Where I've Landed After 400+ Pairs

Three years ago, I was intrigued by Neurolens but skeptical.

Today, I'm a believer in what it can do for the right patient with Binocular Vision Dysfunction.

That doesn't mean Neurolens treats every headache. It doesn't. It doesn't replace appropriate investigation of new, unusual, severe or progressive symptoms. And there are still important scientific questions about exactly who responds best and why.

But I no longer have much uncertainty about the larger clinical question.

Binocular Vision Dysfunction and visual stress can absolutely contribute to headaches, eyestrain, neck discomfort, motion sensitivity and visual disorientation. And in appropriately selected patients, reducing that burden with contoured prism can make an extraordinary difference.

My job is to figure out when the eyes appear to be part of the problem.

I've become much better at doing that.

And when I'm wrong, I have structured the way I offer Neurolens so that the patient doesn't have to pay for my mistake.

That's probably the best summary of where I've landed after three years:

I believe strongly in Neurolens.

I believe even more strongly in selecting the right BVD patient.

And when those two things come together, it can be one of the most rewarding treatments I offer.

Many of these patients have spent years being told their eyes are fine.

Often, they are.

Their eyes are healthy. Their prescription is minimal. They see 20/20.

But healthy eyes are not the same as comfortable vision.

And 20/20 vision is not the same as a visual system that feels good to live in.